Literature DB >> 8560090

Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia?

Y Homma1, Y Ohtsuka, K Tanimura, H Kusaka, M Munakata, Y Kawakami, H Ogasawara.   

Abstract

We prospectively followed 68 patients diagnosed as idiopathic interstitial pneumonia (IIP) over a period of 1-11 years. Thirteen patients (19%) subsequently developed systemic manifestations of collagen vascular diseases (CVD) and were diagnosed as having had interstitial pneumonia as the sole presentation of CVD (CVD-IP). Compared with the 55 IIP patients, the 13 CVD-IP patients were relatively younger, predominantly female, and had a lower incidence of dust inhalation in their history. They also had a higher erythrocyte sedimentation rate, higher incidence of the x-ray finding of discoid atelectasis in the lower lung fields, and a better prognosis than the IIP patients. However, these features did not clearly distinguish the two groups. We conclude that the patients clinically and/or histologically defined as suffering from IIP cannot be distinguished from CVD-IP patients before systemic signs of CVD appear in the latter group.

Entities:  

Mesh:

Year:  1995        PMID: 8560090     DOI: 10.1159/000196457

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  12 in total

1.  Connective tissue disease-associated interstitial lung disease: a call for clarification.

Authors:  Aryeh Fischer; Sterling G West; Jeffrey J Swigris; Kevin K Brown; Roland M du Bois
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

2.  Clinical significance of serum autoantibodies in idiopathic interstitial pneumonia.

Authors:  Bo Hyoung Kang; Jin Kyeong Park; Jae Hyung Roh; Jin Woo Song; Chang Keun Lee; Miyoung Kim; Se Jin Jang; Thomas V Colby; Dong Soon Kim
Journal:  J Korean Med Sci       Date:  2013-05-02       Impact factor: 2.153

3.  BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.

Authors:  Anthony K Shum; Mohammad Alimohammadi; Catherine L Tan; Mickie H Cheng; Todd C Metzger; Christopher S Law; Wint Lwin; Jaakko Perheentupa; Helene Bour-Jordan; Jean Claude Carel; Eystein S Husebye; Filippo De Luca; Christer Janson; Ravishankar Sargur; Noémie Dubois; Merja Kajosaari; Paul J Wolters; Harold A Chapman; Olle Kämpe; Mark S Anderson
Journal:  Sci Transl Med       Date:  2013-10-09       Impact factor: 17.956

4.  Connective Tissue Disease-associated Interstitial Lung Disease: A review.

Authors:  Markus Gutsche; Glenn D Rosen; Jeffrey J Swigris
Journal:  Curr Respir Care Rep       Date:  2012-09-21

5.  Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features.

Authors:  Daniel Antunes Silva Pereira; Olívia Meira Dias; Guilherme Eler de Almeida; Mariana Sponholz Araujo; Letícia Barbosa Kawano-Dourado; Bruno Guedes Baldi; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro Carvalho
Journal:  J Bras Pneumol       Date:  2015 Mar-Apr       Impact factor: 2.624

Review 6.  Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF).

Authors:  Adelle S Jee; Stephen Adelstein; Jane Bleasel; Gregory J Keir; MaiAnh Nguyen; Joanne Sahhar; Peter Youssef; Tamera J Corte
Journal:  J Clin Med       Date:  2017-05-04       Impact factor: 4.241

7.  Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: protocol for a systematic review.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  BMJ Open       Date:  2018-03-08       Impact factor: 2.692

8.  Current Perspectives On Emerging Biomarkers For Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Authors:  Isabelle Amigues; Deepa Ramadurai; Jeffrey J Swigris
Journal:  Open Access Rheumatol       Date:  2019-10-15

9.  Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis.

Authors:  Masato Kono; Yutaro Nakamura; Noriyuki Enomoto; Dai Hashimoto; Tomoyuki Fujisawa; Naoki Inui; Masato Maekawa; Takafumi Suda; Thomas V Colby; Kingo Chida
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

Review 10.  Interpretation of autoantibody positivity in interstitial lung disease and lung-dominant connective tissue disease.

Authors:  Daniel Antunes Silva Pereira; Alexandre de Melo Kawassaki; Bruno Guedes Baldi
Journal:  J Bras Pneumol       Date:  2013 Nov-Dec       Impact factor: 2.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.